Levomethamphetamine

Levomethamphetamine
INN: Levmetamfetamine
Clinical data
Routes of; administration	Medical: Inhalation (nasal); Recreational: Oral, intravenous, insufflation, inhalation, suppository
Legal status
Legal status	AU: S8 (Controlled drug); BR: Class A3 (Psychoactive drugs); CA: Schedule I; DE: Anlage II (Authorized trade only, not prescriptible); UK: Class A; US: Schedule II and for specific formulations OTC; UN: Psychotropic Schedule II;
Pharmacokinetic data
Metabolism	Hepatic
Elimination half-life	13 - 15 hours
Excretion	Renal
Identifiers
	IUPAC name (R)-N-methyl-1-phenyl-propan-2-amine;
CAS Number	33817-09-3 ;
PubChem CID	36604;
ChemSpider	33634 ;
UNII	Y24T9BT2Q2;
KEGG	D02291 ;
CompTox Dashboard (EPA)	DTXSID30187474 ;
ECHA InfoCard	100.046.974
Chemical and physical data
Formula	C10H15N
Molar mass	149.23 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES N([C@@H](Cc1ccccc1)C)C;
	InChI InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m1/s1 ; Key:MYWUZJCMWCOHBA-SECBINFHSA-N ;
	(what is this?) (verify)

Levomethamphetamine is the levorotatory (L-enantiomer) form of methamphetamine. Levomethamphetamine is a sympathomimetic vasoconstrictor that is the active ingredient in some over-the-counter (OTC) nasal decongestant inhalers in the United States.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.